Andy Zang

Andy (Peng) Zang currently serves as Vice President, Head of Business Development and Strategic Planning at CARsgen Therapeutics, overseeing business development and project management since March 2021. Prior experience includes positions at Roche and Bristol Myers Squibb, where responsibilities encompassed strategic planning for hematology and oncology product portfolios. Andy Zang has a strong background in marketing and brand management from tenure at Glaxosmithkline, focusing on pain relief products across Greater China. Educational qualifications include a PhD in Dentistry and a Bachelor's degree with a double major in Economics from Peking University.